Page 8 - 2021_12-Haematologica-web

haematologica Journal of the Ferrata Storti Foundation
3206 Combined transcriptome and proteome profiling of SRC kinase activity in healthy and E527K defective megakaryocytes Lore De Kock et al.
https://doi.org/10.3324/haematol.2021.279248
3211 Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma Samer A. Srour et al.
https://doi.org/10.3324/haematol.2021.279179
3215 Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
David Baker, et al.
https://doi.org/10.3324/haematol.2021.278779
3219 Allogeneic hematopoietic cell transplantation outcomes in patients with Richter’s transformation Haesook T. Kim et al.
https://doi.org/10.3324/haematol.2021.279033
3223 BET inhibitors enhance embryonic and fetal globin expression in erythroleukemia cell lines John Z. Cao et al.
https://doi.org/10.3324/haematol.2021.278791
3228 Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdOx1 nCov-19 vaccine Mariangela Scavone et al.
https://doi.org/10.3324/haematol.2021.279345
3232 Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell
lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
Fabian Knörr et al.
https://doi.org/10.3324/haematol.2021.278971
3236 Lower respiratory tract infection with Staphylococcus aureus in sickle-cell adult patients with severe acute chest syndrome - the STAPHACS Study
Alexandre Elabbadi et al.
https://doi.org/10.3324/haematol.2021.278827
3240 Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial
Gail J. Roboz et al.
https://doi.org/10.3324/haematol.2021.279174
Case Reports
3245 Dominance of an UBA1 mutant clone over a CALR mutant clone: from essential thrombocytemia to VEXAS Mehdi Hage-Sleiman et al.
https://doi.org/10.3324/haematol.2021.279418
3249 Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins - a rational for monitoring immunoglobulin G levels
Jonathan Douxfils et al.
https://doi.org/10.3324/haematol.2021.279509
Haematologica 2021; vol. 106 no. 12 - December 2021 http://www.haematologica.org/